{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T21:23:51Z","timestamp":1786224231837,"version":"3.56.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Motivation: Human serum albumin (HSA), the most abundant plasma protein is well known for its extraordinary binding capacity for both endogenous and exogenous substances, including a wide range of drugs. Interaction with the two principal binding sites of HSA in subdomain IIA (site 1) and in subdomain IIIA (site 2) controls the free, active concentration of a drug, provides a reservoir for a long duration of action and ultimately affects the ADME (absorption, distribution, metabolism, and excretion) profile. Due to the continuous demand to investigate HSA binding properties of novel drugs, drug candidates and drug-like compounds, a support vector machine (SVM) model was developed that efficiently predicts albumin binding. Our SVM model was integrated to a free, web-based prediction platform (http:\/\/albumin.althotas.com). Automated molecular docking calculations for prediction of complex geometry are also integrated into the web service. The platform enables the users (i) to predict if albumin binds the query ligand, (ii) to determine the probable ligand binding site (site 1 or site 2), (iii) to select the albumin X-ray structure which is complexed with the most similar ligand and (iv) to calculate complex geometry using molecular docking calculations. Our SVM model and the potential offered by the combined use of in silico calculation methods and experimental binding data is illustrated.<\/jats:p><jats:p>Contact: \u00a0eszter.hazai@virtuadrug.com<\/jats:p><jats:p>Supplementary information: \u00a0Supplementary data are available at Bioinformatics online.<\/jats:p>","DOI":"10.1093\/bioinformatics\/btr284","type":"journal-article","created":{"date-parts":[[2011,5,19]],"date-time":"2011-05-19T02:22:22Z","timestamp":1305771742000},"page":"1806-1813","source":"Crossref","is-referenced-by-count":123,"title":["Evaluation of drug\u2013human serum albumin binding interactions with support vector machine aided online automated docking"],"prefix":"10.1093","volume":"27","author":[{"given":"Ferenc","family":"Zsila","sequence":"first","affiliation":[{"name":"1 Department of Molecular Pharmacology, Institute of Biomolecular Chemistry, Chemical Research Center, H-1025 Budapest, Pusztaszeri \u00fat 59-67., 2Virtua Drug, Ltd., H\u22121015 Budapest, Csalog\u00e1ny st. 4C, 3Delta Services, Ltd., H-1033 Budapest, Szentendrei st. 39 \u2013 53, 4Department of Measurement and Information Systems, Budapest University of Technology and Economics, Budapest and 5Omixon Zrt, Szuk utca 9, H-9082 Nyul, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Bikadi","sequence":"additional","affiliation":[{"name":"1 Department of Molecular Pharmacology, Institute of Biomolecular Chemistry, Chemical Research Center, H-1025 Budapest, Pusztaszeri \u00fat 59-67., 2Virtua Drug, Ltd., H\u22121015 Budapest, Csalog\u00e1ny st. 4C, 3Delta Services, Ltd., H-1033 Budapest, Szentendrei st. 39 \u2013 53, 4Department of Measurement and Information Systems, Budapest University of Technology and Economics, Budapest and 5Omixon Zrt, Szuk utca 9, H-9082 Nyul, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Malik","sequence":"additional","affiliation":[{"name":"1 Department of Molecular Pharmacology, Institute of Biomolecular Chemistry, Chemical Research Center, H-1025 Budapest, Pusztaszeri \u00fat 59-67., 2Virtua Drug, Ltd., H\u22121015 Budapest, Csalog\u00e1ny st. 4C, 3Delta Services, Ltd., H-1033 Budapest, Szentendrei st. 39 \u2013 53, 4Department of Measurement and Information Systems, Budapest University of Technology and Economics, Budapest and 5Omixon Zrt, Szuk utca 9, H-9082 Nyul, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hari","sequence":"additional","affiliation":[{"name":"1 Department of Molecular Pharmacology, Institute of Biomolecular Chemistry, Chemical Research Center, H-1025 Budapest, Pusztaszeri \u00fat 59-67., 2Virtua Drug, Ltd., H\u22121015 Budapest, Csalog\u00e1ny st. 4C, 3Delta Services, Ltd., H-1033 Budapest, Szentendrei st. 39 \u2013 53, 4Department of Measurement and Information Systems, Budapest University of Technology and Economics, Budapest and 5Omixon Zrt, Szuk utca 9, H-9082 Nyul, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"Pechan","sequence":"additional","affiliation":[{"name":"1 Department of Molecular Pharmacology, Institute of Biomolecular Chemistry, Chemical Research Center, H-1025 Budapest, Pusztaszeri \u00fat 59-67., 2Virtua Drug, Ltd., H\u22121015 Budapest, Csalog\u00e1ny st. 4C, 3Delta Services, Ltd., H-1033 Budapest, Szentendrei st. 39 \u2013 53, 4Department of Measurement and Information Systems, Budapest University of Technology and Economics, Budapest and 5Omixon Zrt, Szuk utca 9, H-9082 Nyul, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Berces","sequence":"additional","affiliation":[{"name":"1 Department of Molecular Pharmacology, Institute of Biomolecular Chemistry, Chemical Research Center, H-1025 Budapest, Pusztaszeri \u00fat 59-67., 2Virtua Drug, Ltd., H\u22121015 Budapest, Csalog\u00e1ny st. 4C, 3Delta Services, Ltd., H-1033 Budapest, Szentendrei st. 39 \u2013 53, 4Department of Measurement and Information Systems, Budapest University of Technology and Economics, Budapest and 5Omixon Zrt, Szuk utca 9, H-9082 Nyul, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter","family":"Hazai","sequence":"additional","affiliation":[{"name":"1 Department of Molecular Pharmacology, Institute of Biomolecular Chemistry, Chemical Research Center, H-1025 Budapest, Pusztaszeri \u00fat 59-67., 2Virtua Drug, Ltd., H\u22121015 Budapest, Csalog\u00e1ny st. 4C, 3Delta Services, Ltd., H-1033 Budapest, Szentendrei st. 39 \u2013 53, 4Department of Measurement and Information Systems, Budapest University of Technology and Economics, Budapest and 5Omixon Zrt, Szuk utca 9, H-9082 Nyul, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,5,18]]},"reference":[{"key":"2023012512012613500_B1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.2042-7158.1995.tb03274.x","article-title":"The effect of co-administered drugs on oxaprozin binding to human serum albumin","volume":"47","author":"Aubry","year":"1995","journal-title":"J. Pharm. Pharmacol."},{"key":"2023012512012613500_B2","doi-asserted-by":"crossref","first-page":"38731","DOI":"10.1074\/jbc.M005460200","article-title":"Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures","volume":"275","author":"Bhattacharya","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2023012512012613500_B3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1758-2946-1-15","article-title":"Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock","volume":"1","author":"Bikadi","year":"2009","journal-title":"J. Cheminform."},{"key":"2023012512012613500_B4","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1345\/aph.1L306","article-title":"Probable interaction between warfarin and torsemide","volume":"42","author":"Bird","year":"2008","journal-title":"Ann. Pharmacother."},{"key":"2023012512012613500_B5","doi-asserted-by":"crossref","first-page":"7486","DOI":"10.1016\/j.bmc.2010.08.052","article-title":"A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions","volume":"18","author":"Buttar","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"2023012512012613500_B6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0065-3233(08)60640-3","article-title":"Structure of serum albumin","volume":"45","author":"Carter","year":"1994","journal-title":"Adv. Protein Chem."},{"key":"2023012512012613500_B7","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/0006-2952(85)90636-7","article-title":"Diclofenac binding to albumin and lipoproteins in human serum","volume":"34","author":"Chamouard","year":"1985","journal-title":"Biochem. Pharmacol."},{"key":"2023012512012613500_B8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/med.10039","article-title":"In silico prediction of drug-binding strengths to human serum albumin","volume":"23","author":"Colmenarejo","year":"2003","journal-title":"Med. Res. Rev."},{"key":"2023012512012613500_B9","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1021\/jm010960b","article-title":"Cheminformatic models to predict binding affinities to human serum albumin","volume":"44","author":"Colmenarejo","year":"2001","journal-title":"J. Med. Chem."},{"key":"2023012512012613500_B10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1569-2558(03)33003-6","article-title":"Plasma albumin as a fatty acid carrier","volume":"33","author":"Curry","year":"2003","journal-title":"Adv. Mol. Cell Biol."},{"key":"2023012512012613500_B11","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2133\/dmpk.24.342","article-title":"Lessons from the crystallographic analysis of small molecule binding to human serum albumin","volume":"24","author":"Curry","year":"2009","journal-title":"Drug Metab. Pharmacokinet."},{"key":"2023012512012613500_B12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/1869","article-title":"Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites","volume":"5","author":"Curry","year":"1998","journal-title":"Nat. Struct. Biol."},{"key":"2023012512012613500_B13","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/0040-4020(80)80168-2","article-title":"Iterative partial equalization of orbital electronegativity - a rapid access to atomic charges","volume":"36","author":"Gasteiger","year":"1980","journal-title":"Tetrahedron"},{"key":"2023012512012613500_B14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jmb.2005.07.075","article-title":"Structural basis of the drug-binding specificity of human serum albumin","volume":"353","author":"Ghuman","year":"2005","journal-title":"J. Mol. Biol."},{"key":"2023012512012613500_B15","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1021\/ci030019w","article-title":"Modeling drug albumin binding affinity with E-state topological structure representation","volume":"43","author":"Hall","year":"2003","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"2023012512012613500_B16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0003-2670(01)01515-X","article-title":"Prediction of human serum albumin-drug binding affinity without albumin","volume":"454","author":"Hanai","year":"2002","journal-title":"Anal. Chim. Acta"},{"key":"2023012512012613500_B17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jps.2600800410","article-title":"A quantitative structure-activity relationship approach to the minimization of albumin binding","volume":"80","author":"Hersey","year":"1991","journal-title":"J. Pharm. Sci."},{"key":"2023012512012613500_B18","doi-asserted-by":"crossref","DOI":"10.1002\/9780470116449.ch6","volume-title":"Applications of support vector machines in chemistry","author":"Ivanciuc","year":"2007"},{"key":"2023012512012613500_B19","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/BF02262246","article-title":"Quantitative structure-enationselective retention relationships for the chromatography of 1,4\u2013benzodiazepines on a human serum albumin based HPLC chiral stationary phase: An approach to the computational prediction of retention and enantioselectivity","volume":"33","author":"Kaliszan","year":"1992","journal-title":"Chromatographia"},{"key":"2023012512012613500_B20","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0006-2952(02)01074-2","article-title":"Predicting plasma protein binding of drugs: a new approach","volume":"64","author":"Kratochwil","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"2023012512012613500_B21","doi-asserted-by":"crossref","first-page":"8897","DOI":"10.1021\/j100389a010","article-title":"DREIDING: a generic force-field for molecular simulations","volume":"94","author":"Mayo","year":"1990","journal-title":"J. Phys. Chem."},{"key":"2023012512012613500_B22","doi-asserted-by":"crossref","first-page":"22804","DOI":"10.1074\/jbc.M100575200","article-title":"Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I","volume":"276","author":"Petitpas","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2023012512012613500_B23","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.1073\/pnas.1137188100","article-title":"Structural basis of albumin-thyroxine interactions and familial dysalbuminemic hyperthyroxinemia","volume":"100","author":"Petitpas","year":"2003","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2023012512012613500_B24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jsb.2010.10.004","article-title":"Structural basis of binding of fluorescent, site-specific dansylated amino acids to human serum albumin","volume":"174","author":"Ryan","year":"2011","journal-title":"J. Struct. Biol."},{"key":"2023012512012613500_B25","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jmb.2006.06.028","article-title":"Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis","volume":"361","author":"Simard","year":"2006","journal-title":"J. Mol. Biol."},{"key":"2023012512012613500_B26","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0026-895X(25)10691-3","article-title":"The characterization of two specific drug binding sites on human serum albumin","volume":"11","author":"Sudlow","year":"1975","journal-title":"Mol. Pharmacol."},{"key":"2023012512012613500_B27","first-page":"1052","article-title":"Further characterization of specific drug binding sites on human serum albumin","volume":"12","author":"Sudlow","year":"1976","journal-title":"Mol. Pharmacol."},{"key":"2023012512012613500_B28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF03190876","article-title":"The role of the protein-binding on the mode of drug action as well the interactions with other drugs","volume":"33","author":"Tesseromatis","year":"2008","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"2023012512012613500_B29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"2023012512012613500_B30","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/0006-2952(84)90668-3","article-title":"The binding of aryl carboxylic acid derivatives to human serum albumin - A structure-activity study","volume":"33","author":"Urien","year":"1984","journal-title":"Biochem. Pharmacol."},{"key":"2023012512012613500_B31","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1021\/ci049820b","article-title":"QSAR models for the prediction of binding affinities to human serum albumin using the heuristic method and a support vector machine","volume":"44","author":"Xue","year":"2004","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"2023012512012613500_B32","first-page":"E12","article-title":"Circular dichroism simulation shows a site-II-to-site-I displacement of human serum albumin-bound diclofenac by ibuprofen","volume":"1","author":"Yamasaki","year":"2000","journal-title":"AAPS PharmSciTech"},{"key":"2023012512012613500_B33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jsb.2006.08.015","article-title":"Effect of human serum albumin on drug metabolism: structural evidence of esterase activity of human serum albumin","volume":"157","author":"Yang","year":"2007","journal-title":"J. Struct. Biol."},{"key":"2023012512012613500_B34","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1021\/jm050362n","article-title":"A critical assessment of docking programs and scoring functions","volume":"49","author":"Warren","year":"2006","journal-title":"J. Med. Chem."},{"key":"2023012512012613500_B35","doi-asserted-by":"crossref","first-page":"29953","DOI":"10.1074\/jbc.M104628200","article-title":"Affinity of human serum albumin for bilirubin varies with albumin concentration and buffer composition: results of a novel ultrafiltration method","volume":"276","author":"Weisiger","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2023012512012613500_B36","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1039\/c0ob00124d","article-title":"Combination of chiroptical, absorption and fluorescence spectroscopic methods reveals multiple, hydrophobicity-driven human serum albumin binding of the antimalarial atovaquone and related hydroxynaphthoquinone compounds","volume":"8","author":"Zsila","year":"2010","journal-title":"Org. Biomol. Chem."},{"key":"2023012512012613500_B37","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6807-3-6","article-title":"Crystal structural analysis of human serum albumin complexed with hemin and fatty acid","volume":"3","author":"Zunszain","year":"2003","journal-title":"BMC Struct. Biol."},{"key":"2023012512012613500_B38","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jmb.2008.06.016","article-title":"Crystallographic analysis of human serum albumin complexed with 4Z,15E-bilirubin-IXa","volume":"381","author":"Zunszain","year":"2008","journal-title":"J. Mol. Biol."}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/27\/13\/1806\/48871330\/bioinformatics_27_13_1806.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/27\/13\/1806\/48871330\/bioinformatics_27_13_1806.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:39:53Z","timestamp":1741192793000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/27\/13\/1806\/185331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,18]]},"references-count":38,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2011,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btr284","relation":{},"ISSN":["1367-4811","1367-4803"],"issn-type":[{"value":"1367-4811","type":"electronic"},{"value":"1367-4803","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,7,1]]},"published":{"date-parts":[[2011,5,18]]}}}